↓ Skip to main content

Cancer Vaccines

Overview of attention for book
Cover of 'Cancer Vaccines'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Single-Step Antigen Loading and Maturation of Dendritic Cells Through mRNA Electroporation of a Tumor-Associated Antigen and a TriMix of Costimulatory Molecules
  3. Altmetric Badge
    Chapter 2 Generation of Multiple Peptide Cocktail-Pulsed Dendritic Cells as a Cancer Vaccine
  4. Altmetric Badge
    Chapter 3 Pulsing Dendritic Cells with Whole Tumor Cell Lysates
  5. Altmetric Badge
    Chapter 4 Antigen Trapping by Dendritic Cells for Antitumor Therapy
  6. Altmetric Badge
    Chapter 5 Ex Vivo Loading of Autologous Dendritic Cells with Tumor Antigens
  7. Altmetric Badge
    Chapter 6 Tumor antigen-/cytokine-pulsed dendritic cells in therapy against lymphoma.
  8. Altmetric Badge
    Chapter 7 Dendritic Cells Primed with Protein–Protein Fusion Adjuvant
  9. Altmetric Badge
    Chapter 8 Antigen-specific mRNA transfection of autologous dendritic cells.
  10. Altmetric Badge
    Chapter 9 Electroporation of dendritic cells with autologous total RNA from tumor material.
  11. Altmetric Badge
    Chapter 10 Dendritic Cells Transfected with Adenoviral Vectors as Vaccines
  12. Altmetric Badge
    Chapter 11 Genetic Modification of Dendritic Cells with RNAi.
  13. Altmetric Badge
    Chapter 12 Fast Monocyte-Derived Dendritic Cell-Based Immunotherapy
  14. Altmetric Badge
    Chapter 13 Intratumoral Injection of BCG-CWS-Pretreated Dendritic Cells Following Tumor Cryoablation
  15. Altmetric Badge
    Chapter 14 Exploiting the CD1d-iNKT Cell Axis for Potentiation of DC-Based Cancer Vaccines.
  16. Altmetric Badge
    Chapter 15 Modification of T lymphocytes to express tumor antigens.
  17. Altmetric Badge
    Chapter 16 Genetic modification of mouse effector and helper T lymphocytes expressing a chimeric antigen receptor.
  18. Altmetric Badge
    Chapter 17 Genetic modification of cytotoxic T lymphocytes to express cytokine receptors.
  19. Altmetric Badge
    Chapter 18 Monitoring the Frequency and Function of Regulatory T Cells and Summary of the Approaches Currently Used to Inhibit Regulatory T Cells in Cancer Patients
  20. Altmetric Badge
    Chapter 19 Cytokine activation of natural killer cells.
  21. Altmetric Badge
    Chapter 20 Loading of Acute Myeloid Leukemia Cells with Poly(I:C) by Electroporation
  22. Altmetric Badge
    Chapter 21 Autologous Tumor Cells Engineered to Express Bacterial Antigens
  23. Altmetric Badge
    Chapter 22 Tumor Cell Transformation Using Antisense Oligonucleotide
  24. Altmetric Badge
    Chapter 23 The direct display of costimulatory proteins on tumor cells as a means of vaccination for cancer immunotherapy.
  25. Altmetric Badge
    Chapter 24 Cloning variable region genes of clonal lymphoma immunoglobulin for generating patient-specific idiotype DNA vaccine.
  26. Altmetric Badge
    Chapter 25 Heat Shock Proteins Purified from Autologous Tumors Using Antibody-Based Affinity Chromatography
  27. Altmetric Badge
    Chapter 26 Invariant Chain-Peptide Fusion Vaccine Using HER-2/neu
  28. Altmetric Badge
    Chapter 27 TLR-9 Agonist Immunostimulatory Sequence Adjuvants Linked to Cancer Antigens.
  29. Altmetric Badge
    Chapter 28 Production of Multiple CTL Epitopes from Multiple Tumor-Associated Antigens.
  30. Altmetric Badge
    Chapter 29 Preparation of Polypeptides Comprising Multiple TAA Peptides.
  31. Altmetric Badge
    Chapter 30 Idiotype Vaccine Production Using Hybridoma Technology
  32. Altmetric Badge
    Chapter 31 Preparation of Cancer-Related Peptide Cocktails that Target Heterogeneously Expressed Antigens
  33. Altmetric Badge
    Chapter 32 Making an Avipoxvirus Encoding a Tumor-Associated Antigen and a Costimulatory Molecule
  34. Altmetric Badge
    Chapter 33 Bacterial vectors for the delivery of tumor antigens.
  35. Altmetric Badge
    Chapter 34 Preparation of Peptide microspheres using tumor antigen-derived peptides.
  36. Altmetric Badge
    Chapter 35 Production of antigen-loaded biodegradable nanoparticles and uptake by dendritic cells.
  37. Altmetric Badge
    Chapter 36 Development of Plasmid–Lipid Complexes for Direct Intratumoral Injection
  38. Altmetric Badge
    Chapter 37 The use of dendritic cells for Peptide-based vaccination in cancer immunotherapy.
  39. Altmetric Badge
    Chapter 38 Advances in host and vector development for the production of plasmid DNA vaccines.
  40. Altmetric Badge
    Chapter 39 Challenges facing the development of cancer vaccines.
  41. Altmetric Badge
    Chapter 40 Future of cancer vaccines.
Attention for Chapter 11: Genetic Modification of Dendritic Cells with RNAi.
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
3 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Genetic Modification of Dendritic Cells with RNAi.
Chapter number 11
Book title
Cancer Vaccines
Published in
Methods in molecular biology, March 2014
DOI 10.1007/978-1-4939-0345-0_11
Pubmed ID
Book ISBNs
978-1-4939-0344-3, 978-1-4939-0345-0
Authors

Song XT, Xiao-Tong Song

Abstract

Gene silencing with RNAi is an invaluable technique in cell biology to knock down the target gene expression. Dendritic cells (DC) are the most effective antigen-presenting cells (APC), and the efficacy of antigen presentation is tightly controlled by the stimulatory as well as inhibitory mechanisms. In recent studies, RNAi technology has been employed to silence the expression of the intrinsic inhibitors of antigen presentation in DC, improving the efficacy of DC vaccines against tumor antigens in pre-clinical studies. Here, we describe the technique of using siRNA oligonucleotides, adenovirus expressing shRNA (Ad-shRNA), or lentivirus expressing shRNA (Lv-shRNA) to knock down inhibitors of antigen presentation in both mouse and human DC.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 67%
Student > Doctoral Student 1 33%
Readers by discipline Count As %
Agricultural and Biological Sciences 2 67%
Biochemistry, Genetics and Molecular Biology 1 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 November 2014.
All research outputs
#20,242,779
of 22,770,070 outputs
Outputs from Methods in molecular biology
#9,862
of 13,090 outputs
Outputs of similar age
#189,674
of 221,023 outputs
Outputs of similar age from Methods in molecular biology
#94
of 160 outputs
Altmetric has tracked 22,770,070 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,090 research outputs from this source. They receive a mean Attention Score of 3.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 221,023 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 160 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.